Top Buy
Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▲ | Target price | Potential |
---|---|---|---|---|---|---|---|
Pro-Dex Inc. | 15 | 0 | 0 | 0 | €16.90 | - | - |
Axsome Therapeutics Inc | 2 | 0 | 0 | 0 | €69.82 | €100.00 | 43.225% |
Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.47 | €9.21 | 1842.405% |
Rhythm Pharmaceuticals | 15 | 0 | 2 | 0 | €37.20 | €45.98 | 23.602% |
Motus GI Holdings Inc. | 2 | 0 | 0 | 0 | €0.43 | €2.33 | 443.991% |
Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.67 | €3.70 | 121.823% |
Merck & Co. Inc. | 28 | 1 | 1 | 0 | €121.20 | €124.93 | 3.077% |
Catalyst Pharmaceutical Partners Inc | 11 | 0 | 1 | 0 | €15.31 | €24.13 | 57.682% |
Drägerwerk AG & Co. KGaA ST | 2 | 0 | 0 | 0 | €45.60 | - | - |
Medtronic plc | 9 | 1 | 0 | 0 | €77.85 | €93.46 | 20.045% |
EssilorLuxottica SA | 3 | 0 | 0 | 0 | €208.30 | €204.50 | -1.824% |
Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
Fresenius Medical Care AG & Co KGaA ST | 5 | 0 | 0 | 0 | €41.49 | €48.50 | 16.896% |
Olympus Corp. | 1 | 0 | 0 | 0 | €14.82 | - | - |
Trinity Biotech ADR | 22 | 0 | 0 | 0 | €0.41 | - | - |
Immutep LTD ADR | 1 | 0 | 0 | 0 | €2.60 | €4.00 | 53.846% |
Verastem Inc. | 10 | 0 | 1 | 0 | €12.10 | €24.63 | 103.593% |
Xeris Biopharma Holdings Inc. | 5 | 0 | 1 | 0 | €1.82 | €4.16 | 129.267% |
Abbott Laboratories | 16 | 0 | 2 | 0 | €96.11 | €116.81 | 21.535% |
UCB S.A. | 2 | 0 | 0 | 0 | €122.80 | - | - |
Cigna Corp. | 17 | 0 | 2 | 0 | €315.60 | €342.35 | 8.476% |
Vertex Pharmaceuticals Inc. | 45 | 2 | 6 | 0 | €402.10 | €408.36 | 1.556% |
Perrigo Co. plc | 3 | 0 | 0 | 0 | €27.78 | €35.99 | 29.537% |
Myriad Genetics | 6 | 2 | 1 | 0 | €23.40 | €24.18 | 3.337% |
Novavax Inc. | 6 | 3 | 4 | 2 | €11.85 | €17.59 | 48.457% |